See more : Swicorp Wabel Reit Fund (4345.SR) Income Statement Analysis – Financial Results
Complete financial analysis of China Health Industries Holdings, Inc. (CHHE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China Health Industries Holdings, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Shandong Jintai Group Co., Ltd. (600385.SS) Income Statement Analysis – Financial Results
- Starry Group Holdings, Inc. (STRY) Income Statement Analysis – Financial Results
- Kura Sushi USA, Inc. (KRUS) Income Statement Analysis – Financial Results
- Quality Online Education Group Inc. (QOEG) Income Statement Analysis – Financial Results
- Agenus Inc. (AGEN) Income Statement Analysis – Financial Results
China Health Industries Holdings, Inc. (CHHE)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
About China Health Industries Holdings, Inc.
China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. It offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, and hemp frozen age nourishing creams. The company also provides health supplements, including Sailuozhi soft capsule, which is made from frog oil, soybean isoflavone, procyanidine, and vitamin E for freckle removal and skin moisture supplements under the QunLe brand; and propolis and black ant capsule that is made from propolis, black ant, acanthopanax, and astragalus root under the Kindlink brand. In addition, it offers health products for acne removal, relieving eyestrain, enhancing bone density, enhancing memory, enhancing nutritional anemia and chloasma, relaxing bowels and promoting the discharge of lead, enhancing immunity and relieving physical fatigue, and dispelling chloasma, as well as iron and multivitamin, and mineral supplements. Further, the company manufactures and sells various types of medical drugs. It primarily sells its products through sales agents. China Health Industries Holdings, Inc. is based in Harbin City, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 111.58K | 267.00 | 6.49M | 9.93M | 9.28M | 6.55M | 6.37M | 7.82M | 10.23M | 9.71M | 7.73M | 58.94M | 62.78M | 43.11M | 10.97M | 0.00 | 842.14K | 747.06K |
| Cost of Revenue | 111.36K | 1.75K | 2.85M | 2.66M | 2.24M | 4.28M | 4.07M | 5.50M | 7.29M | 7.32M | 6.75M | 34.93M | 33.34M | 20.16M | 4.88M | 0.00 | 417.58K | 334.40K |
| Gross Profit | 220.00 | -1.48K | 3.64M | 7.27M | 7.04M | 2.28M | 2.30M | 2.32M | 2.94M | 2.39M | 974.34K | 24.00M | 29.44M | 22.95M | 6.09M | 0.00 | 424.56K | 412.67K |
| Gross Profit Ratio | 0.20% | -554.68% | 56.09% | 73.25% | 75.87% | 34.71% | 36.14% | 29.62% | 28.71% | 24.66% | 12.61% | 40.73% | 46.90% | 53.23% | 55.53% | 0.00% | 50.41% | 55.24% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 156.74K | 444.95K | 311.18K | 1.39M | 557.89K | 29.21K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.65M | 0.00 | 0.00 | 0.00 | 0.00 | 483.03K | 674.32K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00M | 0.00 | 0.00 | 0.00 | 0.00 | 12.15K | 51.93K |
| SG&A | 1.29M | 934.93K | 1.17M | 1.78M | 1.86M | 2.25M | 1.83M | 1.96M | 2.12M | 1.97M | 1.12M | 4.65M | 4.61M | 4.84M | 1.63M | 97.40K | 495.18K | 726.25K |
| Other Expenses | 557.51K | 711.52K | 609.70K | 601.07K | 610.82K | 353.46K | 219.08K | 39.69K | 38.85K | 61.56K | 182.69K | 63.46K | 46.58K | 79.39K | 53.73K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.84M | 1.65M | 1.78M | 2.38M | 2.48M | 2.74M | 2.47M | 2.60M | 2.71M | 3.11M | 1.75M | 5.03M | 6.05M | 5.48M | 1.72M | 97.40K | 495.18K | 726.25K |
| Cost & Expenses | 1.95M | 1.65M | 4.63M | 5.04M | 4.71M | 7.02M | 6.54M | 8.10M | 10.00M | 10.43M | 8.50M | 39.96M | 39.38M | 25.64M | 6.59M | 97.40K | 912.76K | 1.06M |
| Interest Income | 113.62K | 157.86K | 137.49K | 125.63K | 114.23K | 110.59K | 146.67K | 72.33K | 97.43K | 111.81K | 247.51K | 304.62K | 227.84K | 226.54K | 307.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 577.00 | 157.16K | 782.00 | 1.00 | 6.00 | 49.41K | 159.88K | 102.25K | 125.61K | 111.76K | 247.51K | 304.62K | 27.32K | 20.58K | 66.00K | -34.90K | 94.93K | 18.27K |
| Depreciation & Amortization | 686.68K | 830.54K | 878.79K | 805.44K | 817.68K | 668.75K | 644.38K | 636.46K | 814.94K | 1.14M | 230.39K | 110.26K | 83.58K | 79.39K | 74.51K | 11.77K | 21.67K | 16.15K |
| EBITDA | -1.16M | -817.38K | 2.90M | 5.82M | 5.38M | 665.94K | 1.72M | 1.24M | 1.18M | 589.28K | -936.43K | 19.39M | 23.71M | 17.80M | 4.45M | 109.84K | 123.35K | -347.43K |
| EBITDA Ratio | -1,035.97% | 179,598.88% | 44.67% | 58.62% | 59.39% | 10.14% | 14.71% | 7.49% | 11.52% | 6.07% | -3.86% | 32.91% | 37.77% | 41.23% | 40.56% | 0.00% | 3.97% | -39.81% |
| Operating Income | -1.84M | -351.02K | 1.86M | 4.89M | 4.56M | -466.86K | -167.52K | -282.53K | 226.74K | -720.14K | -776.50K | 18.98M | 23.40M | 17.47M | 4.37M | -97.40K | -70.62K | -313.58K |
| Operating Income Ratio | -1,651.39% | -131,466.67% | 28.71% | 49.26% | 49.18% | -7.12% | -2.63% | -3.61% | 2.22% | -7.42% | -10.05% | 32.20% | 37.27% | 40.52% | 39.87% | 0.00% | -8.39% | -41.98% |
| Total Other Income/Expenses | 1.43M | 1.30M | 157.68K | 124.88K | 128.78K | 413.10K | 1.08M | 786.11K | 10.68K | 61.61K | 247.51K | 304.62K | 200.52K | 235.21K | -65.43K | 93.35K | -267.23K | -68.27K |
| Income Before Tax | -408.77K | -351.02K | 2.02M | 5.02M | 4.69M | -53.76K | 917.11K | 503.57K | 237.41K | -658.53K | -528.99K | 19.28M | 23.60M | 17.70M | 4.31M | -34.90K | -165.55K | -331.86K |
| Income Before Tax Ratio | -366.35% | -131,466.67% | 31.14% | 50.51% | 50.57% | -0.82% | 14.39% | 6.44% | 2.32% | -6.78% | -6.85% | 32.72% | 37.59% | 41.07% | 39.28% | 0.00% | -19.66% | -44.42% |
| Income Tax Expense | 0.00 | 2.93K | 730.46K | 1.47M | 1.38M | 263.07K | 458.09K | 343.99K | 234.91K | -60.00 | 23.93K | 4.81M | 5.92M | 4.45M | 1.48M | 34.90K | 94.93K | 18.27K |
| Net Income | -408.77K | -353.95K | 1.29M | 3.55M | 3.31M | -316.83K | 1.31M | 159.60K | 2.56K | -658.47K | -552.92K | 14.48M | 17.67M | 13.25M | 2.82M | -34.90K | -165.55K | -331.86K |
| Net Income Ratio | -366.35% | -132,565.54% | 19.89% | 35.75% | 35.65% | -4.83% | 20.59% | 2.04% | 0.03% | -6.78% | -7.16% | 24.56% | 28.15% | 30.75% | 25.75% | 0.00% | -19.66% | -44.42% |
| EPS | -0.01 | -0.01 | 0.02 | 0.05 | 0.05 | 0.00 | 0.02 | 0.00 | 0.00 | -0.01 | -0.01 | 0.23 | 0.28 | 0.21 | 0.05 | -0.02 | -1.71 | -0.18 |
| EPS Diluted | -0.01 | -0.01 | 0.02 | 0.05 | 0.05 | 0.00 | 0.02 | 0.00 | 0.00 | -0.01 | -0.01 | 0.23 | 0.28 | 0.21 | 0.05 | -0.02 | -1.71 | -0.18 |
| Weighted Avg Shares Out | 65.54M | 65.54M | 65.54M | 65.54M | 65.54M | 65.54M | 65.68M | 65.62M | 63.04M | 62.24M | 62.24M | 62.24M | 62.24M | 62.24M | 62.23M | 2.23M | 96.63K | 1.83M |
| Weighted Avg Shares Out (Dil) | 65.54M | 65.54M | 65.54M | 65.54M | 65.54M | 65.54M | 65.68M | 65.62M | 63.04M | 62.24M | 62.24M | 62.24M | 62.24M | 62.24M | 62.23M | 2.23M | 96.63K | 1.83M |
Source: https://incomestatements.info
Category: Stock Reports